Pharmacy Law and Policy Symposium Self-Study

 

 

 

2021 Pharmacy Law and Policy Symposium Self-study

 

MPA Law and Policy Symposium Now Available as a Self-Study

If you missed the opportunity to participate in the MPA Virtual Law and Policy Symposium that happened on April 28, 2021, the recorded series of programs are being offered for home study credit, including four hours of pharmacy law and one hour accredited to meet Michigan's ethics and jurisprudence educational requirement. Topics include: drug supply chain security act and counterfeit drugs, FDA and health-system pharmacy compounding, pharmacy law and ethics update, DEA methods of diversion and drug trends and pharmacy law and regulatory update. Click here for more information and to purchase.

 Rates:

MPA Pharmacist Member $75

Pharmacist Nonmember $150

MPA Technician Member $30

Technician Nonmember $60

MPA Student Member $15

Student Nonmember $30

 

PROGRAMS

 

DRUG SUPPLY CHAIN SECURITY ACT AND COUNTERFEIT DRUGS

 

Ilisa Bernstein, Pharm.D., JD, senior vice president, pharmacy practice and government affairs, American Pharmacists Association, North Bethesda, Md. and  Shabbir Imber Safdar, executive director, Partnership for Safe Medicines, San Francisco, Calif.

ACPE Universal Activity #0112-0000-21-208-H03-P & 0112-0000-21-208-H03-T; 1.0 contact hour

At the end of this activity, participants should be able to:

1. Describe  the Drug Supply Chain Security Act (DSCSA or track and trace law).

2. Identify pharmacists responsibilities under the DSCSA.

3. Discuss how pharmacists can protect patients from getting substandard and counterfeit drugs.

4. Describe a recent incident of counterfeits in America and how they reached patients through a break in the secure supply chain.

5. List examples of how black market distributors circumvent the supply chain protections.

6. Identify a method of verifying pharmaceutical wholesalers.

 

FDA AND HEALTH-SYSTEM PHARMACY COMPOUNDING

Rosilend Lawson, branch chief, Division of Compounding Policy and Outreach, Office of Compounding Quality and Compliance, US Food and Drug Administration, Silver Spring, Md. and Tom Kraus, vice president, government relations, American Society of Health-System Pharmacists, Washington, D.C.

ACPE Universal Activity #0112-0000-21-209-L07-P & 0112-0000-21-209-L07-T; 1.0 contact hour

At the end of this activity, participants should be able to:

1. Recognize the differences between compounding under section 503A of the Federal Food Drug and Cosmetic Act, and section 503B.

2. Identify the conditions for compounding under section 503A.

3. Discuss FDA's recent policy documents.

 

PHARMACY LAW AND ETHICS UPDATE

Kim Sveska, R.Ph., JD, principle, lawyer, Foley, Baron, Metzger & Juip, PLLC, Milford, Mich.

ACPE Universal Activity #0112-0000-21-212-L03-P & 0112-0000-21-212-L03-T; 1.0 contact hour

At the end of this activity, participants should be able to:

1. Identify changes to Michigan Administrative rules effecting pharmacists, technicians, and pharmacies.

2. Discuss how to resolve potential ethical conflicts.

3. Discuss the likelihood of a pharmacist or technician being named as a defendant in a malpractice lawsuit given new case law.

 

DEA OVERVIEW: METHODS OF DIVERSION AND DRUG TRENDS

Kathy Federico, diversion program manager, Drug Enforcement Administration, Detroit, Mich.

ACPE Universal Activity #0112-0000-21-210-L03-P & 0112-0000-21-210-L03-T; 1.0 contact hour

At the end of this activity, participants should be able to:

1. Describe the Controlled Substance Act and its implementing regulations regarding controlled substance prescriptions.

2. Identify mechanisms for reporting of suspicious fraudulent conduct and/or behavior.

3. Identify best practices for prevention of diversion of controlled substances.

 

PHARMACY LAW AND REGULATORY UPDATE

Farah Jalloul, Pharm.D., director of professional development, Michigan Pharmacists Association, Lansing, Mich. and Brian Sapita, manager of government affairs, Michigan Pharmacists Association, Lansing, Mich.

ACPE Universal Activity #0112-0000-21-211-L03-P & 0112-0000-21-211-L03-T; 1.0 contact hour

At the end of this activity, participants should be able to:

1. Discuss how to for potential and upcoming regulatory changes currently being discussed with policy makers.

2. Identify mechanisms to be in compliance with recent law and policy changes.

3. Identify relevant changes to pharmacy law and policy taking effect in 2021.

 

 

CANCELLATION AND REFUND POLICY

Refunds will not be granted after purchase.